Characterization of GRK5 as a novel regulator of rhabdomyosarcoma tumor cell growth and self-renewal.

Oncotarget · 2020 · PMC7185065 · PMID 32363002

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Targeted disruption of GRK5 in Rh30 showed a trend of reduced self-renewal capacity but was not statistically significant ( p -value = 0.086).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.